首页> 外文期刊>Bone marrow transplantation >The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
【24h】

The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients

机译:植入后不久的扭矩Teno病毒血浆DNA负荷的动力学预测了同种异体造血干细胞移植受体中高级别CMV DNAMIA的风险

获取原文
获取原文并翻译 | 示例
       

摘要

Monitoring Torque teno virus (TTV) DNA load helps to estimate the risk of opportunistic infections in solid organ transplant recipients. We investigated whether the early kinetic pattern of plasma TTV DNA load after allogeneic hematopoietic stem cell transplantation (allo-HSCT) associates with subsequent CMV and EBV DNAemia. This study included 71 allo-HSCT patients. We found that the area under the curve (AUC) for log(10) TTV DNA loads quantified by days 20 and 30 after transplantation (TTV DNA load AUC(20-30)), was significantly lower (P = 0.036) in patients who subsequently developed CMV DNAemia requiring preemptive antiviral therapy (n = 17) than in those who did not (n = 8) or had no CMV DNAemia (n = 19). Patients displaying TTV DNA load AUC(20-30) = 2.8 copies x days x mL(-1) were more likely to have high-level CMV DNAemia. A trend towards a direct correlation between TTV DNA AUC(20-30) and CMV-specific interferon-gamma CD8+ T-cell counts by day +30 was noted (P = 0.095). However, this dynamic parameter was not useful for anticipating the occurrence of either CMV recurrences (n = 12) or EBV DNAemia (n = 34). In summary, it may be possible to identify a subset of allo-HSCT patients at a high risk of developing high-level CMV DNAemia by analyzing the kinetics of plasma TTV DNA load early after engraftment.
机译:监测扭矩Teno病毒(TTV)DNA负荷有助于估计固体器官移植受体中的机会主义感染风险。我们研究了同种异体造血干细胞移植(Allo-HSCT)与随后的CMV和EBV DNAEMIA后的血浆TTV DNA负荷的早期动力学模式。本研究包括71例Allo-HSCT患者。我们发现,在移植后20和30的曲线(AUC)下的曲线(10)TTV DNA载荷(TTV DNA载荷AUC(20-30)),患者显着降低(P = 0.036)随后开发CMV DNAEMIA,需要先发制人的抗病毒治疗(n = 17),而不是在没有(n = 8)或没有CMV DNAEMIa(n = 19)。显示TTV DNA载荷AUC(20-30)的患者& = 2.8拷贝x天x ml(-1)更可能具有高级别的CMV DNAEMIA。注意到TTV DNA AUC(20-30)和CMV特异性干扰素-GAMMA CD8 + T细胞计数在第+30天之间直接相关的趋势(p = 0.095)。然而,这种动态参数对于预期CMV复发(n = 12)或EBV DNAEMIA(n = 34)的发生是没有用的。总之,通过在植入早期分析血浆TTV DNA负荷的动力学,可以以高级别CMV DNAEMIA的高风险识别Allo-HSCT患者的子集。

著录项

  • 来源
    《Bone marrow transplantation》 |2018年第2期|共8页
  • 作者单位

    Hosp Clin Univ Inst Res INCLIVA Microbiol Serv Valencia Spain;

    Hosp Clin Univ Inst Res INCLIVA Hematol Serv Valencia Spain;

    Hosp Clin Univ Inst Res INCLIVA Microbiol Serv Valencia Spain;

    Pisa Univ Hosp North Western Tuscany Blood Bank Pisa Italy;

    Hosp Clin Univ Inst Res INCLIVA Hematol Serv Valencia Spain;

    Pisa Univ Hosp Virol Unit Pisa Italy;

    Hosp Clin Univ Inst Res INCLIVA Hematol Serv Valencia Spain;

    Hosp Clin Univ Inst Res INCLIVA Hematol Serv Valencia Spain;

    Pisa Univ Hosp North Western Tuscany Blood Bank Pisa Italy;

    Hosp Clin Univ Inst Res INCLIVA Microbiol Serv Valencia Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号